Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, GlaxoSmithKline, IBM, Max Planck, StoreAge Networking Technologies

Premium

GE Healthcare to Relocate Imaging Research

GE Healthcare will relocate Imaging Research, the Ontario-based bioinformatics and screening company it acquired with Amersham, to Piscataway, NJ, later this month, according to BioInform’s sister publication GenomeWeb News

The company, which employed 45 staffers as of December 2003, will formally shut down its St. Catharines, Ontario, facility before the end of March, according to people familiar with the event. Amersham acquired Imaging Research in 2003, and GE Healthcare bought Amersham one year later.

Imaging Research’s products and services include laboratory-imaging systems and gene expression-analysis software, such as its ArrayVision software for the quantifying gene-expression arrays, and ArrayStat, which analyzes expression array data.

The company also sells ultra-high throughput screening platforms, such as LEADseeker, and the IN Cell Analyzer 1000 automated cell-screening system.


Glaxo to Use Partek 6.0

Partek has licensed its Partek 6.0 data-mining software to the GlaxoSmithKline cheminformatics department in Research Triangle Park, NC, the company said last week.

Financial details of the deal were not disclosed.


IBM Offers Blue Gene on Tap

IBM will offer on-demand access to a Blue Gene supercomputer housed at a new Deep Computing Capacity on Demand Center in Rochester, MN.

IBM customers will be able to remotely access up to 5.7 teraflops of peak performance through the Blue Gene system via a secure virtual private network and pay only for the amount of capacity reserved, the company said.

The company said the service should be attractive to “customers in market segments that have traditionally not been able to effectively access a supercomputer at a price within their budgets.”

Pricing details for the on-demand service were not provided.


Max Planck to Use DNAStar Software

Germany’s Max Planck Society has signed a “broad” license agreement for DNAStar’s bioinformatics software, according to the company’s European distributor, GATC Biotech.

The Max Planck Society purchased a site license for DNAStar’s Lasergene 6, StarBlast, and GenVision packages.

The agreement will provide access to the software and technical support to all research departments of the Max Planck Institutes.


Zurich Genomics Center Opts for StoreAge SAN

Storage-area-network provider StoreAge Networking Technologies said last week that the Functional Genomics Center Zurich (FGCZ) is using its StoreAge SVM (Storage Virtualization Manager) SAN storage management system.

The deployment was led by ABC Systems, StoreAge’s distributor in Switzerland.

FGCZ’s SAN now includes IBM xSeries file, database, and backup servers in a Microsoft Windows environment and different classes of storage systems.

Financial terms of the agreement were not provided.

 

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.